1-8 of 8
F. van Rhee
Close
Sort by
Journal Articles

Killer Immunoglobulin-Like Receptor Ligand (KIR-Lig) Mismatched Natural Killer (NK) Cell Transfusions for Multiple Myeloma (MM).

J. Shi, MD, PhD, S. Szmania, BS, N. Rosen, BS, A. Moreno, BS, R. Walker, MD, B. DuPont, MD, K. Hsu, MD, L.A. Baxter-Lowe, PhD, J. Shaughnessy, PhD, B. Barlogie, MD, PhD, M. Cottler-Fox, MD, G. Tricot, MD, PhD, F. van Rhee, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3472.
https://doi.org/10.1182/blood.V106.11.3472.3472
Published: 2005
Journal Articles

Collection of Peripheral Blood Stem Cells in 668 Patients with Multiple Myeloma Treated on Total Therapy II (UARK 98-026).

K. A. Hollmig, MD, J. M. Stover, BA, M. C. Fox, MD, L. C. Jackson, BSN, G. Talamo, MD, A. Fassas, MD, M. Zangari, MD, C. K. Lee, MD, F. Van Rhee, MD, PhD, E. Anaissie, MD, G. Tricot, MD, PhD, B. Barlogie, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 5236.
https://doi.org/10.1182/blood.V104.11.5236.5236
Published: 2004
Journal Articles

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

F. Dazzi, R. M. Szydlo, C. Craddock, N. C. P. Cross, J. Kaeda, A. Chase, E. Olavarria, F. van Rhee, E. Kanfer, J. F. Apperley, J. M. Goldman
Journal: Blood
Blood (2000) 95 (1): 67–71.
https://doi.org/10.1182/blood.V95.1.67
Published: 2000
Journal Articles

p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias

F van Rhee, A Hochhaus, F Lin, JV Melo, JM Goldman, NC Cross
Journal: Blood
Blood (1996) 87 (12): 5213–5217.
https://doi.org/10.1182/blood.V87.12.5213.bloodjournal87125213
Published: 1996
Journal Articles

Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation

F Lin, F van Rhee, JM Goldman, NC Cross
Journal: Blood
Blood (1996) 87 (10): 4473–4478.
https://doi.org/10.1182/blood.V87.10.4473.bloodjournal87104473
Published: 1996
Journal Articles

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

A Hochhaus, F Lin, A Reiter, H Skladny, PJ Mason, F van Rhee, PC Shepherd, NC Allan, R Hehlmann, JM Goldman, NC Cross
Journal: Blood
Blood (1996) 87 (4): 1549–1555.
https://doi.org/10.1182/blood.V87.4.1549.bloodjournal8741549
Published: 1996
Journal Articles

Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient

A Spencer, RM Szydlo, PA Brookes, E Kaminski, S Rule, F van Rhee, KN Ward, G Hale, H Waldmann, JM Hows
Journal: Blood
Blood (1995) 86 (9): 3590–3597.
https://doi.org/10.1182/blood.V86.9.3590.bloodjournal8693590
Published: 1995
Journal Articles

Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse

F van Rhee, F Lin, JO Cullis, A Spencer, NC Cross, A Chase, B Garicochea, J Bungey, J Barrett, JM Goldman
Journal: Blood
Blood (1994) 83 (11): 3377–3383.
https://doi.org/10.1182/blood.V83.11.3377.3377
Published: 1994